top of page
Developing Novel Cyclic Peptides to Combat Life – Threatening Infectious Diseases
AJK Biopharmaceutical is developing new classes of peptide-based drugs to treat the world’s most challenging infectious diseases. New antimicrobial drugs are needed to meet the urgent public health threat of antimicrobial resistance.
Clinical Development of Novel Anti-Infective Drugs
bottom of page